Back to Search Start Over

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Authors :
Goba A
Khan SH
Fonnie M
Fullah M
Moigboi A
Kovoma A
Sinnah V
Yoko N
Rogers H
Safai S
Momoh M
Koroma V
Kamara FK
Konowu E
Yillah M
French I
Mustapha I
Kanneh F
Foday M
McCarthy H
Kallon T
Kallon M
Naiebu J
Sellu J
Jalloh AA
Gbakie M
Kanneh L
Massaly JL
Kargbo D
Kargbo B
Vandi M
Gbetuwa M
Gevao SM
Sandi JD
Jalloh SC
Grant DS
Blyden SO
Crozier I
Schieffelin JS
McLellan SL
Jacob ST
Boisen ML
Hartnett JN
Cross RW
Branco LM
Andersen KG
Yozwiak NL
Gire SK
Tariyal R
Park DJ
Haislip AM
Bishop CM
Melnik LI
Gallaher WR
Wimley WC
He J
Shaffer JG
Sullivan BM
Grillo S
Oman S
Garry CE
Edwards DR
McCormick SJ
Elliott DH
Rouelle JA
Kannadka CB
Reyna AA
Bradley BT
Yu H
Yenni RE
Hastie KM
Geisbert JB
Kulakosky PC
Wilson RB
Oldstone MB
Pitts KR
Henderson LA
Robinson JE
Geisbert TW
Saphire EO
Happi CT
Asogun DA
Sabeti PC
Garry RF
Source :
The Journal of infectious diseases [J Infect Dis] 2016 Oct 15; Vol. 214 (suppl 3), pp. S110-S121. Date of Electronic Publication: 2016 Jul 11.
Publication Year :
2016

Abstract

Background: Kenema Government Hospital (KGH) has developed an advanced clinical and laboratory research capacity to manage the threat of Lassa fever, a viral hemorrhagic fever (VHF). The 2013-2016 Ebola virus (EBOV) disease (EVD) outbreak is the first to have occurred in an area close to a facility with established clinical and laboratory capacity for study of VHFs.<br />Methods: Because of its proximity to the epicenter of the EVD outbreak, which began in Guinea in March 2014, the KGH Lassa fever Team mobilized to establish EBOV surveillance and diagnostic capabilities.<br />Results: Augustine Goba, director of the KGH Lassa laboratory, diagnosed the first documented case of EVD in Sierra Leone, on 25 May 2014. Thereafter, KGH received and cared for numbers of patients with EVD that quickly overwhelmed the capacity for safe management. Numerous healthcare workers contracted and lost their lives to EVD. The vast majority of subsequent EVD cases in West Africa can be traced back to a single transmission chain that includes this first diagnosed case.<br />Conclusions: Responding to the challenges of confronting 2 hemorrhagic fever viruses will require continued investments in the development of countermeasures (vaccines, therapeutic agents, and diagnostic assays), infrastructure, and human resources.<br /> (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1537-6613
Volume :
214
Issue :
suppl 3
Database :
MEDLINE
Journal :
The Journal of infectious diseases
Publication Type :
Academic Journal
Accession number :
27402779
Full Text :
https://doi.org/10.1093/infdis/jiw239